Viewing Study NCT04971928


Ignite Creation Date: 2025-12-26 @ 11:14 AM
Ignite Modification Date: 2026-01-13 @ 11:20 PM
Study NCT ID: NCT04971928
Status: COMPLETED
Last Update Posted: 2022-09-27
First Post: 2021-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GSK3228836 View
None Hepatitis B View
None Child-Pugh B (CP-B) cirrhosis View
None Child-Pugh A (CP-A) cirrhosis View
None Pharmacokinetics View
None B-Assured View